SCHEMBL32665074

SCHEMBL32665074

Cc1cccc(-c2nnc3ccc(Br)c(C)n23)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
NPSR1 Q6W5P4 4/20 0.40
TSHR P16473 4/20 0.40
DPP4 P27487 8/20 0.39
KMT2A Q03164 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
USP2 O75604 3/20 0.39
MEN1 O00255 3/20 0.39
HPGD P15428 2/20 0.39
LMNA P02545 2/20 0.39
HTT P42858 2/20 0.39
THRB P10828 1/20 0.39
RECQL P46063 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
ATM Q13315 1/20 0.38
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4202785 0.74 DAPK3 (0.43) ALDH1A1TSHRKMT2AMEN1HPGD
SCHEMBL31200166 0.72 SMN1; SMN2 (0.47) L3MBTL1SMN1; SMN2KDM4E
SCHEMBL32665199 0.72 KDM4E (0.50) ALDH1A1L3MBTL1NPSR1TSHRDPP4
SCHEMBL13319606 0.68 ALDH1A1 (0.50) ALDH1A1L3MBTL1TSHRKMT2ASMN1; SMN2
SCHEMBL14504719 0.67 ALDH1A1 (0.59) ALDH1A1L3MBTL1NPSR1TSHRKMT2A
SCHEMBL13745072 0.67 MAPK14 (0.39) L3MBTL1SMN1; SMN2
SCHEMBL30498956 0.66 KDM4E (0.58) ALDH1A1L3MBTL1NPSR1TSHRKMT2A
SCHEMBL24401671 0.66 DPP4 (0.54) ALDH1A1L3MBTL1NPSR1TSHRDPP4
SCHEMBL29617977 0.66 DPP4 (0.54) ALDH1A1L3MBTL1NPSR1TSHRDPP4
SCHEMBL28027753 0.65 ALDH1A1 (0.46) ALDH1A1L3MBTL1NPSR1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022124-A1 THERAPEUTIC COMPOUNDS AND METHODS UNIV MINNESOTA (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022124-A1 THERAPEUTIC COMPOUNDS AND METHODS NR5A1, CYP17A1, CNR1 ALDH1A1 663/4885L3MBTL1 3391/4885NPSR1 321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.